Physician profile
Lucy Cheng
NPI 1235580085
$2,861.90
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $81.30 · 2021: $978 · 2022: $1,114 · 2023: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $569.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $665.71 | 2021-2023 | Tremfya, Stelara, Simponi |
| Abbvie INC. | $589.00 | 2019-2023 | Skyrizi, Rinvoq |
| Incyte Corporation | $237.82 | 2021-2023 | Opzelura |
| Lilly USA, LLC | $219.12 | 2021-2023 | Taltz, Olumiant |
| Amgen INC. | $156.53 | 2021-2023 | Otezla |
| Vyne Pharmaceuticals INC. | $123.61 | 2020-2021 | |
| Pfizer INC. | $122.67 | 2020-2022 | |
| Genzyme Corporation | $108.81 | 2020-2023 | |
| Regeneron Healthcare Solutions, INC. | $102.94 | 2021-2023 | Dupixent |
| Ucb, INC. | $98.54 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $97.56 | 2022-2023 | Sotyktu |
| Leo Pharma INC. | $78.29 | 2022-2023 | Adbry |
| Novartis Pharmaceuticals Corporation | $73.13 | 2021-2023 | |
| Sun Pharmaceutical Industries INC. | $70.33 | 2021-2023 | Winlevi |
| Dermavant Sciences, INC. | $34.05 | 2023 | Vtama |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $32.07 | 2021-2022 | |
| Epi Health, LLC | $18.37 | 2022 | |
| Mission Pharmacal Company | $14.37 | 2021 | |
| Galderma Laboratories, L.P. | $13.32 | 2021 | |
| Mayne Pharma Commercial LLC | $5.66 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucy Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.